CheckRare

CheckRare


Acromegaly Research Highlights: ENDO 2023

This 30-minute CME-accredited program highlights the latest clinical research about acromegaly, a rare endocrine disorder. Common symptoms include subtle skeletal overgrowth; soft tissue swelling (tongue, heart, kidney, colon, and vocal cords); unusually prominent forehead and heavy brow ridge; protruding lower jaw; overbite; skin thickening; increased shoe and ring size; hypertension; increased...
CheckRare

Assessing, Monitoring, and Managing Respiratory Involvement in Lysosomal Disorders

Ozlem Gore-Alpan, MD of LDRTC and John Bach, MD, Professor of Neurology at Rutgers School of Medicine discuss best practices to manage respiratory complications in persons with lysosomal disorders. At the end of this activity, participants should be able to: - Describe the most common LSDs that have pulmonary complications. - Describe best practices to manage pulmonary symptoms in Pompe dis...
CheckRare

Building and Maintaining a Multidisciplinary Team for Lysosomal Disorders

This CME/CE activity with Drs. Ozlem Goker-Aplan and Walla Al-Hertani describes the importance of a multidisciplinary team approach to managing lysosomal diseases, as well as some of the challenges involved in creating and maintaining that team. At the end of this activity, participants should be able to: - Describe the need for a team approach to care - Describe best practices to build a...
CheckRare

Cushing’s Disease Research Highlights: ENDO 2023

This 30-minute CME program highlights the latest clinical research about Cushing’s disease. Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor that leads to excessive levels of cortisol. This CME program, hosted by Lisa Machtigall, MD, Clinical Director, Neuroendocrine & Pituitary Tumor Clinical Center at Massachusetts General Hospital, a...
CheckRare

Managing Cardiomyopathies in Lysosomal Disorders

This CME/CE activity describes the pathophysiologies and management options for lysosomal disease patients with cardiomyopathies. At the end of this activity, participants should be able to: - Describe the role of the cardiologist in the team approach to care - Describe best practices to monitor cardiac symptoms in lysosomal disorders - Describe best practices to treat cardiac symptoms in ...
CheckRare

Myasthenia Gravis and the Complement System

This 45-minute CME-accredited program, hosted by James F Howard Jr, MD, Professor of Neurology, Medicine & Allied Health at The University of North Carolina at Chapel Hill, highlights the connection between the complement system and myasthenia gravis in regards to the pathophysiology and treatment of this rare disease. After participating in the activity, learners should be better able to...
CheckRare

Myasthenia Gravis Research Highlights: AAN 2023

This 30-minute CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction. Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subtype of each patient as well as each patient’s comorbidities. There are currently four drugs approved by the FDA, eculizumab, efg...
CheckRare

New Guidance to Diagnose and Treat Tumor-induced Osteomalacia (TIO)

This 30-minute CME-accredited program, hosted by Aliya Khan, MD, Clinical Professor of Medicine at McMaster University, highlights the best practices to diagnose and treat tumor induced osteomalacia (TIO) based on the recently published global guidance document in the Journal of Internal Medicine. This activity has been designed to meet the educational needs of physicians specializing in neur...
CheckRare

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map